156 related articles for article (PubMed ID: 24052422)
1. Circulating cytokines and gastric cancer risk.
Epplein M; Xiang YB; Cai Q; Peek RM; Li H; Correa P; Gao J; Wu J; Michel A; Pawlita M; Zheng W; Shu XO
Cancer Causes Control; 2013 Dec; 24(12):2245-50. PubMed ID: 24052422
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
[TBL] [Abstract][Full Text] [Related]
4. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
[TBL] [Abstract][Full Text] [Related]
7. Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women.
Wong HL; Rabkin CS; Shu XO; Pfeiffer RM; Cai Q; Ji BT; Yang G; Li HL; Rothman N; Gao YT; Zheng W; Chow WH
Cancer Sci; 2011 Oct; 102(10):1911-5. PubMed ID: 21740481
[TBL] [Abstract][Full Text] [Related]
8. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
9.
Varga MG; Wang T; Cai H; Xiang YB; Gao YT; Ji BT; Pawlita M; Waterboer T; Zheng W; Shu XO; Epplein M
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):342-344. PubMed ID: 29263184
[No Abstract] [Full Text] [Related]
10. Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
Epplein M; Zheng W; Li H; Peek RM; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Xiang YB; Shu XO
Nutr Cancer; 2014; 66(4):550-7. PubMed ID: 24666234
[TBL] [Abstract][Full Text] [Related]
11. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
14. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.
Flores-Luna L; Camorlinga-Ponce M; Hernandez-Suarez G; Kasamatsu E; Martínez ME; Murillo R; Lazcano E; Torres J
Cancer Causes Control; 2013 Feb; 24(2):241-8. PubMed ID: 23184121
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
16. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
[TBL] [Abstract][Full Text] [Related]
17. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.
Jang J; Ma SH; Ko KP; Choi BY; Yoo KY; Park SK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):470-476. PubMed ID: 31740519
[TBL] [Abstract][Full Text] [Related]
19. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
[TBL] [Abstract][Full Text] [Related]
20. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.
Yang JJ; Yang JH; Kim J; Ma SH; Cho LY; Ko KP; Shin A; Choi BY; Kim HJ; Han DS; Eun CS; Song KS; Kim YS; Chang SH; Shin HR; Kang D; Yoo KY; Park SK
Int J Cancer; 2013 May; 132(9):2148-56. PubMed ID: 23001699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]